Publicacións en colaboración con investigadores/as de Stanford University (12)

2021

  1. Consensus on diagnosis and management of Cushing's disease: a guideline update

    The lancet. Diabetes & endocrinology, Vol. 9, Núm. 12, pp. 847-875

2019

  1. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

    The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 8, pp. 618-628

  2. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

    The Lancet, Vol. 394, Núm. 10204, pp. 1169-1180

2018

  1. Alirocumab and cardiovascular outcomes after acute coronary syndrome

    New England Journal of Medicine, Vol. 379, Núm. 22, pp. 2097-2107

  2. Growth hormone research society perspective on biomarkers of gh action in children and adults

    Endocrine Connections, Vol. 7, Núm. 3, pp. R126-R134

2017

  1. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants

    The Lancet, Vol. 389, Núm. 10064, pp. 37-55

2016

  1. A century of trends in adult human height

    eLife, Vol. 5

  2. Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations

    European Journal of Endocrinology

  3. Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19.2 million participants

    The Lancet, Vol. 387, Núm. 10026, pp. 1377-1396

2015

  1. Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: Data from ROCKET AF

    Journal of the American Heart Association, Vol. 5, Núm. 3

  2. Discordant identification of pediatric severe sepsis by research and clinical definitions in the SPROUT international point prevalence study

    Critical Care, Vol. 19, Núm. 1

2008

  1. Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults

    Journal of Endocrinological Investigation, Vol. 31, Núm. 9, pp. 820-838